Amphivena Therapeutics

PharmaceuticalsSeries CSan Francisco, USamphivena.com

Latest round

Series C

Last raised

Sep 2019

Total raised

$28M

Investors

12

About Amphivena Therapeutics

Amphivena Therapeutics, Inc.Founded in 2012 in San Francisco, US, Amphivena Therapeutics, Inc. specializes in creating immunotherapies to combat cancer. The company's strategic focus has remained consistent since its inception.Amphivena Therapeutics develops groundbreaking immunotherapeutic products aimed at treating cancer.Amphivena Therapeutics does not currently generate revenue from product sales, as the company is in the development phase of its therapeutic candidates. plans to utilize these funds to further advance its lead therapeutic candidate. The company is focused on progressing its clinical trials and exploring potential new products, with an emphasis on expanding its market presence in the oncology field.

Who invested in Amphivena Therapeutics

12 investors across 2 rounds

See all investors in Amphivena Therapeutics

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series C

    Sep 24, 2019

    Amount

    $23M

    Investors

    Locked

  2. Series A

    Jul 11, 2013

    Amount

    $4.2M

    Investors

    Locked

Questions about Amphivena Therapeutics

Who invested in Amphivena Therapeutics?

Amphivena Therapeutics has 12 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Amphivena Therapeutics raised?

Amphivena Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did Amphivena Therapeutics last raise money?

Amphivena Therapeutics's most recent round on record is a Series C, in Sep 2019.

What does Amphivena Therapeutics do?

Amphivena Therapeutics is a pharmaceuticals company.

Where is Amphivena Therapeutics headquartered?

Amphivena Therapeutics is headquartered in San Francisco, US.

Which VCs invest in companies like Amphivena Therapeutics?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Amphivena Therapeutics's stage. Their profiles are linked below.

Raising like Amphivena Therapeutics? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.